ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

Study Disproves “Old Saw,” Finds Life No Worse for Cancer Patients

December 3, 1982

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer

August 25, 2006